Consequent to the UK's withdrawal from the EU, this Halsbury paragraph should be read in conjunction with the Veterinary Medicines and Residues (Amendment) (EU Exit) Regulations 2020, SI 2020/1461, pending incorporation of the changes into the text.
The authorisation, manufacture, classification, distribution and administration of veterinary medicinal products are subjects of secondary legislation1, which is considered elsewhere in this work2.
**Trials are provided to all LexisPSL and LexisLibrary content, excluding Practice Compliance, Practice Management and Risk and Compliance, subscription packages are tailored to your specific needs. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and millions of others like it, sign-in to LexisLibrary or register for a free trial.
EXISTING USER? SIGN IN
TAKE A FREE TRIAL
0330 161 1234